About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Arrhythmias
Cardiomyopathy
Circulatory Disorders
Congenital heart disease
Heart Failure
Hyperlipidaemia
Hypertension
Ischaemic heart disease
Valvar diseases
Venous Thromboembolism
Pulmonary Hypertension
103 library items
in Pulmonary Hypertension
Filter results by:
Date Published
2012 (4)
2011 (23)
2010 (12)
2009 (25)
2008 (23)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Cardiovascular Medicine (
remove
)
,
Hypertension (
remove
)
,
Pulmonary Hypertension (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 103
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Horizon scanning: Actelion annonuices positive phase III data for on macitentan for pulmonary arterial hypertension
Source:
Reuters Health News, MarketWatch
,
Date published:
01/05/2012
Category:
2.5.1 Vasodilator antihypertensive drugs
|
New drugs
|
Pulmonary Hypertension
NeLM
Area:
News
Link to Reuters report- subscribers only
Link to MarketWatch report
2.
Ocular safety of chronic use of sildenafil citrate in treatment of pulmonary arterial hypertension: data from phase III study and open label extension
Source:
BMJ
,
Date published:
23/02/2012
Category:
2.5.1 Vasodilator antihypertensive drugs
|
Adverse Drug Reactions
|
Ophthalmology
|
Pulmonary Hypertension
NeLM
Area:
News
Link
3.
Horizon scanning: French approval of IV treprostinil (Remodulin™) for the treatment of pulmonary arterial hypertension
Source:
BioSpace.com
,
Date published:
04/01/2012
Category:
2.5.1 Vasodilator antihypertensive drugs
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Horizon scanning
|
Pulmonary Hypertension
NeLM
Area:
News
Link
4.
Horizon scanning: New Drug Application submitted to FDA for oral treprostinil for the treatment of pulmonary arterial hypertension
Source:
BioSpace.com
,
Date published:
04/01/2012
Category:
2.5.1 Vasodilator antihypertensive drugs
|
Food &Drug Administration (FDA)
|
Horizon scanning
|
Pulmonary Hypertension
NeLM
Area:
News
Link
5.
FDA Drug Safety Communication on use of SSRIs during pregnancy and potential risk of persistent pulmonary hypertension of the newborn
Source:
FDA
,
Date published:
15/12/2011
Category:
4.3.3 Selective serotonin re-uptake inhibitors
|
Drugs in pregnancy
|
Food &Drug Administration (FDA)
|
Mood disorders (including depression)
|
Neonates (0-1 month)
|
Pulmonary Hypertension
NeLM
Area:
News
Link
6.
Development of a pharmacist collaborative care program for pulmonary arterial hypertension
Source:
International Journal of Clinical Pharmacy
,
Date published:
06/12/2011
Category:
Hospital pharmacy
|
Pulmonary Hypertension
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
7.
Pfizer communication: Increased risk of mortality in children with pulmonary hypertension with use of higher than recommended doses of Revatio (sildenafil citrate)
Source:
MHRA, Pfizer
,
Date published:
04/11/2011
Category:
2.5.1 Vasodilator antihypertensive drugs
|
Adverse Drug Reactions
|
Medical staff
|
Medicines and Healthcare products Regulatory Agency (MHRA)
|
Paediatrics
|
Pharmaceutical Industry
|
Pulmonary Hypertension
NeLM
Area:
Evidence
>
Medication Safety
MHRA - Link to Pfizer letter
8.
FDA Drug Safety Communication: Dasatinib (Sprycel®) may increase the risk of pulmonary arterial hypertension
Source:
FDA
,
Date published:
13/10/2011
Category:
8.1.5 Other antineoplastic drugs
|
Adverse Drug Reactions
|
Food &Drug Administration (FDA)
|
Leukaemia
|
Pulmonary Hypertension
NeLM
Area:
News
Link
9.
Conference report: Phase III results for QT1571 (imatinib) in the treatment of pulmonary arterial hypertension
Source:
BioSpace
,
Date published:
28/09/2011
Category:
8.1.5 Other antineoplastic drugs
|
Horizon scanning
|
Pulmonary Hypertension
NeLM
Area:
News
Link
10.
Meta-analysis: Combination therapy no better than monotherapy for pulmonary arterial hypertension
Source:
American Journal of Cardiology
,
Date published:
21/09/2011
Category:
2.5.1 Vasodilator antihypertensive drugs
|
Pulmonary Hypertension
NeLM
Area:
News
Abstract
Results 1 - 10 of 103
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next